The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Chiaki Nakaseko Hisashi Sakamaki Kazuteru Ohashi Noriyoshi Iriyama |
| Publication date | October 16, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |